APWM
AZN icon

Atlas Private Wealth Management’s AstraZeneca AZN Stock Holding History

Atlas Private Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25
Closed -$3K – 394
2020
Q2 		$3K Buy
+25
New +$2.58K ﹤0.01% 404

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Atlas Private Wealth Management's AZN Position: Q3 2020 in Review

Atlas Private Wealth Management sold out of AstraZeneca (AZN) in Q3 2020, closing a stake of 25 shares — an estimated $3K sold.

Atlas Private Wealth Management first reported a position in AZN in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 723 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

  • Atlas Private Wealth Management reported no remaining AstraZeneca position as of Q3 2020 after selling out during the quarter.
  • Atlas Private Wealth Management sold 25 AstraZeneca shares in Q3 2020, an estimated $3K.
  • Atlas Private Wealth Management first reported a position in AstraZeneca in Q2 2020 and held it in 1 quarter.
  • Atlas Private Wealth Management's AstraZeneca position peaked at $3K in Q2 2020.
  • 723 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on Atlas Private Wealth Management's 13F filing for Q3 2020, filed 5 Nov 2020.